A Phase I Trial of Doxil, Bevacizumab and Temsirolimus
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 05 Jun 2017
At a glance
- Drugs Bevacizumab (Primary) ; Doxorubicin liposomal (Primary) ; Temsirolimus (Primary) ; Everolimus
- Indications Cancer
- Focus Adverse reactions
- 26 May 2017 Status changed from completed to active, no longer recruiting.
- 06 Sep 2016 Status changed from active, no longer recruiting to completed.
- 07 Jul 2016 Status changed from recruiting to active, no longer recruiting.